Exposure of chronic obstructive pulmonary disease patients to particles: Respiratory and cardiovascular health effects

被引:96
|
作者
Brauer, M
Ebelt, ST
Fisher, TV
Brumm, J
Petkau, AJ
Vedal, S
机构
[1] Univ British Columbia, Sch Occupat & Environm Hyg, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1Z3, Canada
基金
英国医学研究理事会;
关键词
air pollution; environmental exposure; heart rate; heart rate variability; lung infection; particles;
D O I
10.1038/sj.jea.7500195
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
To examine hypotheses regarding air pollution health effects, we conducted an exploratory study to evaluate relationships between personal and ambient concentrations of particles with measures of cardiopulmonary health in a sample of patients with chronic obstructive pulmonary disease (COPD), Sixteen currently non-stroking COPD patients (mean age=74) residing in Vancouver were equipped with a particle (PM2.5) monitor for seven 24-h periods. Subjects underwent ambulatory heart monitoring, had their lung function and blood pressure ( BP) measured, and recorded symptoms and medication use. Ambient PM2.5, PM10, sulfate, and gaseous pollutant concentrations were monitored at five sites within the study area. Although no associations between air pollution and lung function were statistically significant, an estimated effect of 3% and 1% declines in daily FEV1 change (Delta FEV1) for each 10 mug/m(3) increase in ambient PM10 and PM2.5, respectively, was observed. Increases of 1 mug/m(3) in personal or ambient sulfate were associated with 1.0% and 0.3% declines in Delta FEV1, respectively. Weak associations were observed between particle concentrations and increased supraventricular ex;topic heartbeats and with decreased systolic BP. No consistent associations were observed between any particle metric and diastolic BP, heart rate, or heart rate variability (r-MSSD or SDNN), symptom severity, or bronchodilator use. Of the pollutants measured, ambient PM10 was most consistently associated with health parameters; the use of personal exposures did not improve the strength of any associations or lead to increased effect estimates.
引用
收藏
页码:490 / 500
页数:11
相关论文
共 50 条
  • [1] Exposure of chronic obstructive pulmonary disease patients to particles: Respiratory and cardiovascular health effects
    MICHAEL BRAUER
    STEFANIE T EBELT
    TERI V FISHER
    JOCHEN BRUMM
    A JOHN PETKAU
    SVERRE VEDAL
    Journal of Exposure Science & Environmental Epidemiology, 2001, 11 : 490 - 500
  • [2] RESPIRATORY EFFECTS OF CLOBAZAM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ZAROGOULIDIS, K
    KAKAVELAS, E
    ECONOMIDIS, D
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A184 - A184
  • [3] Effects of theophylline on respiratory drive in patients with chronic obstructive pulmonary disease
    Ashutosh, K
    Sedat, M
    Fragale-Jackson, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (12): : 1100 - 1107
  • [4] Cardiovascular and bone disease in patients with chronic obstructive pulmonary disease
    Sabit, R.
    Bolton, C. E.
    Edwards, P. H.
    Pettit, R. J.
    Evans, W. D.
    McEniery, C. M.
    Wilkinson, I. B.
    Cockcroft, J. R.
    Shale, D. J.
    THORAX, 2006, 61 : II83 - II83
  • [5] Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
    Udrescu, Lucretia
    Sbarcea, Laura
    Mihaicuta, Stefan
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [6] Chronic obstructive pulmonary disease and cardiovascular disease
    Bhatt, Surya P.
    Dransfield, Mark T.
    TRANSLATIONAL RESEARCH, 2013, 162 (04) : 237 - 251
  • [7] The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease
    van Rijn, Anneloes L.
    van Boheemen, Sander
    Sidorov, Igor
    Carbo, Ellen C.
    Pappas, Nikos
    Mei, Hailiang
    Feltkamp, Mariet
    Aanerud, Marianne
    Bakke, Per
    Claas, Eric C. J.
    Eagan, Tomas M.
    Hiemstra, Pieter S.
    Kroes, Aloys C. M.
    de Vries, Jutte J. C.
    PLOS ONE, 2019, 14 (10):
  • [8] Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
    Sata, Makoto
    CIRCULATION JOURNAL, 2010, 74 (02) : 254 - 255
  • [9] Sympathetic Overactivity and Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease
    van Gestel, Arnoldus J. R.
    Kohler, Malcolm
    Clarenbach, Christian F.
    DISCOVERY MEDICINE, 2012, 14 (79) : 359 - 368
  • [10] Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
    de Miguel-Diez, Javier
    Villota, Julio Nunez
    Perez, Salud Santos
    Lorite, Nicolas Manito
    Navarrete, Bernardino Alcazar
    Jimenez, Juan Francisco Delgado
    Soler-Cataluna, Juan Jose
    Figal, Domingo Pascual
    Ecenarro, Patricia Sobradillo
    Doblas, Juan Jose Gomez
    ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (04): : 226 - 237